https://pmc.ncbi.nlm.nih.gov/articles/PMC20238/
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A - PMC
We previously showed that the availability of a nonamer peptide derived from certain HLA class I signal sequences is a necessary requirement for the...
https://pmc.ncbi.nlm.nih.gov/articles/PMC11442982/
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen...
Chimeric antigen receptor (CAR)-modified natural killer (NK) cells show antileukemic activity against acute myeloid leukemia (AML) in vivo. However, NK...
https://www.epo.org/de/boards-of-appeal/decisions/t230781eu1
T 0781/23 (NKG2A inhibition/Innate) vom 30.01.2025
30 01078123nkg2ainhibition